A new research discovery could help more families affected by a rare inherited condition, Perrault Syndrome, get answers about the cause of their hearing loss. Researchers at Manchester University NHS Foundation Trust (MFT) have identified changes in a gene called 'GPN2' that can cause Perrault syndrome — a rare condition linked to severe hearing loss and, in women, ovarian failure....
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for current clinical practice; this is a basic-science genetic discovery that may eventually improve diagnostic gene-panel coverage for Perrault Syndrome, but has no immediate bearing on audiological management.
Identifying GPN2 as a novel genetic cause of Perrault Syndrome expands the known genetic landscape of rare hereditary hearing loss, potentially improving diagnostic yield for families undergoing genetic testing.
- 01GPN2 gene mutations identified as a new genetic cause of Perrault Syndrome by Manchester University NHS Foundation Trust researchers.
- 02Perrault Syndrome is a rare inherited disorder characterised by hearing loss (and ovarian dysfunction in females).
- 03The finding adds GPN2 to the list of genes that should be considered in genetic screening panels for this condition.
- 04Discovery is foundational/basic science; no treatment or intervention was tested.
- 05Published finding reported via RNID (Royal National Institute for Deaf People) blog, indicating public-engagement coverage of the underlying research.
Mutations in the GPN2 gene are a new genetic cause of Perrault Syndrome.
studypartially supportedPerrault Syndrome is a rare inherited condition associated with hearing loss.
guidelinesupported- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with Perrault Syndrome or suspected rare inherited hearing loss
- Intervention
- Genetic sequencing to identify GPN2 mutations
Primary outcomes
Identification of GPN2 mutations as a causative genetic variant for Perrault Syndrome